Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Anzu Special Acquisition Corp I Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 8-K Quarterly results
10/05/2023 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failur...
Docs: "Second Amended and Restated Certificate of Incorporation of the Company",
"Amended and Restated Bylaws of the Company",
"Certificate of Designation of Series A Preferred Stock of the Company",
"Amendment to Letter Agreement, by and among Anzu, the Sponsor and Anzu’s officers and directors",
"Amended and Restated Registration Rights Agreement, by and among Anzu Special Acquisition Corp I, Anzu SPAC GP I LLC and certain stockholders",
"Amendment to Letter Agreement, by and among Anzu, the Sponsor and Anzu’s officers and directors",
"Envoy Medical, Inc. Equity Incentive Plan",
"Envoy Medical, Inc. Employee Stock Purchase Plan",
"Amendment No. 2 to Forward Purchase Agreement",
"List of subsidiaries"
09/29/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
09/27/2023 8-K Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits &...
Docs: "Anzu Special Acquisition Corp I Stockholders Approve Business Combination with Envoy Medical Corporation Tampa, Florida — September 27, 2023 — Anzu Special Acquisition Corp I , announced today that its stockholders voted to approve the Business Combination Agreement with Envoy Medical Corporation , and the transactions contemplated thereby at the Company’ s special meeting of stockholders held on September 27, 2023 . Pursuant to the Business Combination Agreement, Merger Sub will merge with and into Envoy, with Envoy surviving the merger as a wholly owned subsidiary of the Company . Following the closing of the Merger , the Company will be renamed “Envoy Medical, Inc.”, which is referred to herein as “New Envoy.” Over 99% of the votes cast at the Special Meeting were cast in favor of the a..."
08/24/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/04/2023 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
06/30/2023 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/15/2023 S-4 Form S-4 - Registration of securities, business combinations:
04/18/2023 425 Form 425 - Prospectuses and communications, business combinations:
04/18/2023 8-K Quarterly results
04/03/2023 10-K Annual Report for the period ended December 31, 2022
04/03/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
04/03/2023 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review &nbsp...
03/02/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF"
02/24/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
02/24/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "EXTENSION SUPPORT AGREEMENT This EXTENSION SUPPORT AGREEMENT , dated as of [●], 2023 is made by and between Anzu Special Acquisition Corp I, a Delaware corporation , Anzu SPAC GP I LLC, a Delaware limited liability company , and the undersigned holders . WHEREAS, the Sponsor currently holds 10,500,000 shares of Class B common stock, par value $0.0001 per share, of Anzu , which Sponsor Shares shall convert automatically into shares of Class A common stock, par value $0.0001 per share, of Anzu , at the time of the Initial Business Combination ; WHEREAS, Anzu has entered into a letter of intent regarding an Initial Business Combination with Envoy Medical Corporation , a U.S.-based medical device company that has developed and is in early clinical testing of an implanted device that has ..."
02/22/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
02/22/2023 425 Form 425 - Prospectuses and communications, business combinations:
02/22/2023 8-K Investor presentation
Docs: "Investor Presentation"
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
02/09/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Anzu Special Acquisition Corp I Announces Adjournment of Special Meeting of Stockholders Tampa, Florida — February 9, 2023 — Anzu Special Acquisition Corp I , announced today that it convened and then adjourned, without conducting any other business, the Company’ s special meeting of stockholders held on February 9, 2023. The Special Meeting has been adjourned until 9:30 a.m., Eastern time, on February 21, 2023 . The Adjourned Special Meeting will be held virtually via live webcast at https://web.lumiagm.com/274911563. The record date remains the close of business, Eastern Time, on January 17, 2023. At the Adjourned Special Meeting, stockholders will be asked to vote on a proposal to amend the Company’ s amended and restated certificate of incorporation to extend the date by which the Comp..."
02/06/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
02/06/2023 425 Form 425 - Prospectuses and communications, business combinations:
02/06/2023 8-K Quarterly results
01/20/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
12/28/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
10/04/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o...
Docs: "Resignation Letter of Teresa A. Harris",
"Resignation Letter of William Wulfsohn"
05/16/2022 10-Q Quarterly Report for the period ended March 31, 2022
03/31/2022 10-K Annual Report for the period ended December 31, 2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy